Artificial Intelligence in MEdicine Development
The drug development process faces a triple challenge
Rising complexity
Rising costs
Growing pressure on drug prices
AI-MED Trial support pharma sponsors, non-profit organizations, and CROs with cutting-edge AI-powered tools and computational technologies to streamline clinical trials by enhancing design and efficiency, reduce timelines and costs, and mitigate the risks of unfavourable study outcome.